In this episode of SciBud, join your host Rowan as we delve into a groundbreaking discovery about Transcription Factor 4 (TCF4) and its pivotal role in maintaining the identity of endothelial cells, which line our blood vessels and play a crucial part in cardiovascular health. Recent research reveals how TCF4 inhibits endothelial to mesenchymal transition (EndoMT), a process linked to various cardiovascular diseases. By employing advanced techniques like RNA sequencing and chromatin profiling, researchers uncovered that a decrease in TCF4 leads to harmful changes in endothelial cell identity, creating a vicious cycle that exacerbates disease processes. This episode highlights not only the innovative findings regarding TCF4 but also their implications for future therapies and bioimaging techniques. Tune in for an engaging exploration of how these insights could reshape our understanding of endothelial function and open new therapeutic avenues in cardiovascular medicine. Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/229
Fler avsnitt av SciBud: Emerging Discoveries from Bioimaging
Visa alla avsnitt av SciBud: Emerging Discoveries from BioimagingSciBud: Emerging Discoveries from Bioimaging med Galo Garcia finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
